Phenotype of Urine Sediment Cells in Patients with Bladder Cancer
暂无分享,去创建一个
R. Zukov | A. Mazaev | E. Slepov | E. V. Semenov | A. Savchenko | Y. Kozina | R. Zukov
[1] S. Morozov,et al. Modern possibilities of radiological diagnosis of bladder cancer , 2021 .
[2] L. Diéguez,et al. Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies , 2020, Frontiers in Oncology.
[3] Eun Ji Oh,et al. Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma , 2020, Cancers.
[4] F. Sánchez‐Madrid,et al. CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110 , 2020, Journal of Hematology & Oncology.
[5] Chenyang Lu,et al. CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders , 2020, The Journal of Immunology.
[6] M. Ghosh,et al. CD13 regulation of membrane recycling: implications for cancer dissemination , 2019, Molecular & cellular oncology.
[7] D. Enikeev,et al. [Current trends in bladder cancer diagnosis]. , 2018, Urologiia.
[8] Yumei He,et al. Endoplasmic reticulum stress induced LOX‐1+ CD15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma , 2018, Immunology.
[9] U. Bommhardt,et al. CD45 in human physiology and clinical medicine. , 2018, Immunology letters.
[10] J. B. Jensen,et al. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better? , 2017, Scandinavian journal of urology.
[11] А. И. Субботовская,et al. Опыт измерения параметров иммунного статуса с использованием шестицветного цитофлуориметрического анализа , 2015 .
[12] S. Horie,et al. Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer , 2014, International Journal of Clinical Oncology.
[13] Yun Zhang,et al. An anti-human CD13 monoclonal antibody that suppresses the suppressive function of Treg cells. , 2013, Monoclonal antibodies in immunodiagnosis and immunotherapy.
[14] Jacques Ferlay,et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.